Skip to main content
Caplight Logo









Auransa

Auransa

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://www.auransa.com/

Last Round

VC Round

Jan 3, 2019

Est. Valuation

$70.37M

Total Funding Raised

$16.95M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Auransa is a biotechnology company that has developed an AI-driven platform to discover and develop precision medicines for cancer.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Infrastructure

Keywords

drug discoveryprecision medicineAI drug discoveryin silico drug discoverymulti-omicspatient stratificationbiomarker discoverycomputational biologytherapeutic target identificationbiopharmasmall-molecule drugclinical trial optimizationdrug development pipelineAI-native biotechoncology research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Auransa Comparables

Compare Auransa with similar companies based on industry and business-model similarity.

Auransa comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VeriSIM Life
83%
Healx
82%
Aitia
81%

Auransa Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 3, 2019
Series AMay 31, 2017
SeedDec 22, 2014

Key People

Founding team and executive leadership

Pek Lum

Founder And CEO

Founding Team

Auransa Investors

Notable investors and investment history

Auransa investors
InvestorRounds
Lux CapitalSeed, Series A, VC Round
AME Cloud VenturesSeed, Series A, VC Round
11.2 CapitalSeed, Series A, VC Round
DCVC (Data Collective)Seed, Series A, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors grew 399% MoM, from 287 to 1.4K.

  • May 31, 2017

    $14.1M round led by Lux Capital and DCVC.

Auransa Filings

Explore SEC and related filing metadata, where available.

Auransa filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Auransa's valuation, stock price, and market status.

Is Auransa a public or private company?

Auransa is a private company.

What is the current stock price of Auransa?

Auransa is a private company with no public stock price. No recent secondary market data is available.

How much is Auransa worth (valuation)?

Valuation information for Auransa is not publicly available.

Can I buy Auransa stock?

Auransa shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Auransa's last funding round?

Auransa's most recent funding round was VC Round on January 3, 2019.

Who are the main investors in Auransa?

Key investors in Auransa include Lux Capital, AME Cloud Ventures, 11.2 Capital, DCVC (Data Collective).

Will Auransa IPO soon?

No public IPO plans have been announced for Auransa.

How can I track Auransa secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Auransa's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range11
Year Founded2014
Last FundingJan 3, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?